HMNC Brain Health (HMNC) is specialized in the development of innovative therapies against depression and anxiety disorders. Together with partners from academia and investors, the company utilizes prominent research results to generate innovative and marketable concepts.
The company was founded by Florian Holsboer and Carsten Maschmeyer in December 2010 and is located in the heart of Munich. Both founders are dedicated to the aim of optimizing the treatment of depression and anxiety disorders.
By developing new chemical compounds, gene tests and biomarkers, HMNC will provide a decision aid for attending physicians to select the best treatment for each individual patient. With such customized therapies, HMNC applies the concept of personalized treatment to the field of mental disorders. This will lead to an improvement of treatment quality to the benefit of the affected patient and ultimately to an alleviation of the burden on the health care system.